Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.

Molecular and Cellular Biology
Elizabeth S McKennaCharles W M Roberts

Abstract

There is a growing appreciation of the role that epigenetic alterations can play in oncogenesis. However, given the large number of genetic anomalies present in most cancers, it has been difficult to evaluate the extent to which epigenetic changes contribute to cancer. SNF5 (INI1/SMARCB1/BAF47) is a tumor suppressor that regulates the epigenome as a core member of the SWI/SNF chromatin remodeling complex. While the SWI/SNF complex displays potent tumor suppressor activity, it is unknown whether this activity is exerted genetically via maintenance of genome integrity or epigenetically via transcriptional regulation. Here we show that Snf5-deficient primary cells do not show altered sensitivity to DNA damaging agents, defects in gamma-H2AX induction, or an abrogated DNA damage checkpoint. Further, the aggressive malignancies that arise following SNF5 loss are diploid and genomically stable. Remarkably, we demonstrate that most human SNF5-deficient cancers lack genomic amplifications/deletions and, aside from SNF5 loss, are indistinguishable from normal cells on single-nucleotide polymorphism arrays. Finally, we show that epigenetically based changes in transcription that occur following SNF5 loss correlate with the tumor phenotyp...Continue Reading

References

Sep 1, 1990·Genes, Chromosomes & Cancer·E C DouglassP J Houghton
Nov 1, 1993·Nature Genetics·M HarveyL A Donehower
Apr 16, 1998·The Journal of Biological Chemistry·E P RogakouW M Bonner
Oct 16, 1999·American Journal of Human Genetics·N SévenetO Delattre
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·C W RobertsS H Orkin
Jan 9, 2001·Journal of Cellular Physiology·M F DecristofaroB E Weissman
Feb 15, 2001·Nature Genetics·S V TavtigianL A Cannon-Albright
Apr 21, 2001·Molecular and Cellular Biology·C J GuidiS N Jones
May 1, 2002·The EMBO Journal·Ludmila BozhenokPatrick Varga-Weisz
Jul 26, 2002·Molecular and Cellular Biology·Zhi-Kai ZhangGanjam V Kalpana
Oct 17, 2002·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Su Gülsün BerrakLauren A Langford
Nov 16, 2002·Nature Genetics·Nadine CollinsPatrick D Varga-Weisz
Jan 2, 2003·Molecular and Cellular Biology·Satoshi TateishiMasaru Yamaizumi
Aug 5, 2003·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Duane R PilchWilliam M Bonner
Nov 8, 2003·The Journal of Biological Chemistry·Igor OruetxebarriaC Peter Verrijzer
Feb 10, 2004·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Christian H Rickert, Werner Paulus
Feb 18, 2004·Nature Reviews. Cancer·Charles W M Roberts, Stuart H Orkin
May 19, 2005·Cancer Research·Piergiorgio ModenaGabriella Sozzi
Jun 28, 2005·Journal of Neuro-oncology·Hironori FujisawaJunkoh Yamashita
Aug 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mary TsikitisGanjam V Kalpana
Sep 3, 2005·The EMBO Journal·Lionel GreshAgnès Klochendler-Yeivin
Nov 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Michael S IsakoffCharles W M Roberts
Nov 23, 2005·Oncogene·D Alarcon-VargasG V Kalpana
Feb 8, 2006·Neurosurgical Focus·Jaclyn A Biegel

❮ Previous
Next ❯

Citations

Sep 30, 2009·Virchows Archiv : an International Journal of Pathology·Judith V M G Bovée, Pancras C W Hogendoorn
Jul 3, 2013·The Lancet Oncology·Bernadette BrennanFranck Bourdeaut
Jun 10, 2011·Nature Reviews. Cancer·Boris G Wilson, Charles W M Roberts
Oct 28, 2009·Carcinogenesis·C MaenhautW C G van Staveren
Jun 23, 2012·Science·Russell J H Ryan, Bradley E Bernstein
Jul 17, 2012·The Journal of Clinical Investigation·Ryan S LeeCharles W M Roberts
Feb 1, 2012·Epigenetics & Chromatin·Hannes LansWim Vermeulen
Dec 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Melissa E SmithGanjam V Kalpana
Jun 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Michael Y TolstorukovCharles W M Roberts
May 24, 2014·Cancer Genetics·Kimberly H Kim, Charles W M Roberts
Oct 22, 2014·Epigenomics·Katherine A SkultePhillippa C Taberlay
Mar 12, 2013·Cellular and Molecular Life Sciences : CMLS·Covadonga HuidobroMario F Fraga
Jun 19, 2012·Expert Review of Molecular Diagnostics·Thomas MikeskaAlexander Dobrovic
Nov 11, 2009·Genes, Chromosomes & Cancer·Uwe KordesReinhard Schneppenheim
Sep 22, 2012·Pediatric Blood & Cancer·Mark W KieranJaclyn A Biegel
Dec 1, 2012·International Journal of Cancer. Journal International Du Cancer·Yasumichi KuwaharaBernard E Weissman
Feb 26, 2013·Brain Pathology·Ryan S Lee, Charles W M Roberts
Jun 13, 2012·Histopathology·Julien CalderaroYves Allory
Aug 14, 2009·Molecular Carcinogenesis·Jessica DelBoveBernard E Weissman
Jul 26, 2011·Molecular Oncology·Martijn S Luijsterburg, Haico van Attikum
Jul 16, 2013·Pediatric Hematology and Oncology·Kornelius KerlMichael C Frühwald
Dec 19, 2015·Journal of Cellular Physiology·Kazutaka OuchiHajime Hosoi
Apr 26, 2016·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Hongmiao SunYue Zhao
Sep 19, 2016·Journal of Pediatric Surgery·Benjamin A FarberMichael P La Quaglia
Aug 16, 2017·Endocrine-related Cancer·Sock Hoai Chan, Joanne Ngeow
Feb 24, 2009·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Angelina Stojanova, Linda Z Penn
Jan 10, 2020·Expert Review of Molecular Diagnostics·Bryan K LiEric Bouffet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.